These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. Fleckenstein B; Molberg Ø; Qiao SW; Schmid DG; von der Mülbe F; Elgstøen K; Jung G; Sollid LM J Biol Chem; 2002 Sep; 277(37):34109-16. PubMed ID: 12093810 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Detection of Isopeptides between Human Tissue Transglutaminase and Gluten Peptides. Lexhaller B; Ludwig C; Scherf KA Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547042 [TBL] [Abstract][Full Text] [Related]
4. Identification of Isopeptides Between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides. Lexhaller B; Ludwig C; Scherf KA Sci Rep; 2020 May; 10(1):7426. PubMed ID: 32367038 [TBL] [Abstract][Full Text] [Related]
5. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease. Skovbjerg H; Koch C; Anthonsen D; Sjöström H Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629 [TBL] [Abstract][Full Text] [Related]
6. Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl Engstrom N; Saenz-Méndez P; Scheers J; Scheers N Sci Rep; 2017 Mar; 7(1):77. PubMed ID: 28250436 [TBL] [Abstract][Full Text] [Related]
7. A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects. Simon-Vecsei Z; Király R; Bagossi P; Tóth B; Dahlbom I; Caja S; Csosz É; Lindfors K; Sblattero D; Nemes É; Mäki M; Fésüs L; Korponay-Szabó IR Proc Natl Acad Sci U S A; 2012 Jan; 109(2):431-6. PubMed ID: 22198767 [TBL] [Abstract][Full Text] [Related]
8. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease. Dørum S; Qiao SW; Sollid LM; Fleckenstein B J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248 [TBL] [Abstract][Full Text] [Related]
9. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease. Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165 [TBL] [Abstract][Full Text] [Related]
11. Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange. Iversen R; Mysling S; Hnida K; Jørgensen TJ; Sollid LM Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17146-51. PubMed ID: 25404341 [TBL] [Abstract][Full Text] [Related]
12. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. Shan L; Qiao SW; Arentz-Hansen H; Molberg Ø; Gray GM; Sollid LM; Khosla C J Proteome Res; 2005; 4(5):1732-41. PubMed ID: 16212427 [TBL] [Abstract][Full Text] [Related]
13. Susceptibility to transglutaminase of gliadin peptides predicted by a mass spectrometry-based assay. Mamone G; Ferranti P; Melck D; Tafuro F; Longobardo L; Chianese L; Addeo F FEBS Lett; 2004 Mar; 562(1-3):177-82. PubMed ID: 15044021 [TBL] [Abstract][Full Text] [Related]
14. The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Stamnaes J; Fleckenstein B; Sollid LM Biochim Biophys Acta; 2008 Nov; 1784(11):1804-11. PubMed ID: 18793760 [TBL] [Abstract][Full Text] [Related]
15. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize. Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241 [TBL] [Abstract][Full Text] [Related]
16. Structural and mechanistic analysis of Ca Sewa AS; Besser HA; Mathews II; Khosla C Proc Natl Acad Sci U S A; 2024 Jul; 121(28):e2407066121. PubMed ID: 38959038 [TBL] [Abstract][Full Text] [Related]
17. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects. Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408 [TBL] [Abstract][Full Text] [Related]
18. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization. Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572 [TBL] [Abstract][Full Text] [Related]
19. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852 [TBL] [Abstract][Full Text] [Related]
20. Identification of transglutaminase-mediated deamidation sites in a recombinant alpha-gliadin by advanced mass-spectrometric methodologies. Mazzeo MF; De Giulio B; Senger S; Rossi M; Malorni A; Siciliano RA Protein Sci; 2003 Nov; 12(11):2434-42. PubMed ID: 14573857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]